86 related articles for article (PubMed ID: 12547545)
1. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.
Timms JM; Bell A; Flavell JR; Murray PG; Rickinson AB; Traverse-Glehen A; Berger F; Delecluse HJ
Lancet; 2003 Jan; 361(9353):217-23. PubMed ID: 12547545
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications.
Volaric AK; Saleem A; Younes SF; Zhao S; Natkunam Y
Ann Diagn Pathol; 2024 Jun; 70():152286. PubMed ID: 38447253
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated lymphomas decoded.
Bednarska K; Chowdhury R; Tobin JWD; Swain F; Keane C; Boyle S; Khanna R; Gandhi MK
Br J Haematol; 2024 Feb; 204(2):415-433. PubMed ID: 38155519
[TBL] [Abstract][Full Text] [Related]
4. A Case of Epstein-Barr Virus-Negative Post-transplant Lymphoproliferative Disorder in a Solid Organ Transplant Recipient With Untreated Chronic Hepatitis C.
Asiimwe E; Mead M
Cureus; 2024 Jan; 16(1):e53323. PubMed ID: 38435861
[TBL] [Abstract][Full Text] [Related]
5. Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder.
Hatton O; Martinez OM; Esquivel CO
Pediatr Transplant; 2012 May; 16(3):220-9. PubMed ID: 22353174
[TBL] [Abstract][Full Text] [Related]
6. Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.
Chen J
World J Virol; 2012 Dec; 1(6):154-61. PubMed ID: 24175221
[TBL] [Abstract][Full Text] [Related]
7. Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer.
Pearce DR; Akarca AU; De Maeyer RPH; Kostina E; Huebner A; Sivakumar M; Karasaki T; Shah K; Janes SM; McGranahan N; Reddy V; Akbar AN; Moore DA; Marafioti T; Swanton C; Hynds RE
Front Oncol; 2023; 13():1156743. PubMed ID: 37342197
[TBL] [Abstract][Full Text] [Related]
8. Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus.
Hutcheson RL; Chakravorty A; Sugden B
Front Cell Infect Microbiol; 2020; 10():606412. PubMed ID: 33505922
[TBL] [Abstract][Full Text] [Related]
9. Dangerous Liaisons: Gammaherpesvirus Subversion of the Immunoglobulin Repertoire.
Zelazowska MA; McBride K; Krug LT
Viruses; 2020 Jul; 12(8):. PubMed ID: 32717815
[TBL] [Abstract][Full Text] [Related]
10. Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders.
Watanabe M; Kanda J; Hishizawa M; Nishikori M; Kondo T; Yamashita K; Takaori-Kondo A
Ann Hematol; 2020 Jul; 99(7):1565-1573. PubMed ID: 32436013
[TBL] [Abstract][Full Text] [Related]
11. The Global Landscape of EBV-Associated Tumors.
Shannon-Lowe C; Rickinson A
Front Oncol; 2019; 9():713. PubMed ID: 31448229
[TBL] [Abstract][Full Text] [Related]
12. Establishment of hepatocellular carcinoma patient-derived xenografts from image-guided percutaneous biopsies.
Tischfield DJ; Ackerman D; Noji M; Chen JX; Johnson O; Perkons NR; Nadolski GJ; Hunt SJ; Soulen MC; Furth EE; Gade TP
Sci Rep; 2019 Jul; 9(1):10546. PubMed ID: 31332214
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Epstein-Barr virus DNA and Porphyromonas gingivalis in Japanese peri-implantitis patients.
Kato A; Imai K; Sato H; Ogata Y
BMC Oral Health; 2017 Dec; 17(1):148. PubMed ID: 29233156
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma.
Kim YR; Kim SJ; Cheong JW; Chung H; Jang JE; Kim Y; Yang WI; Min YH; Kim JS
Oncotarget; 2017 Nov; 8(54):92312-92323. PubMed ID: 29190917
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated lymphomas.
Shannon-Lowe C; Rickinson AB; Bell AI
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893938
[TBL] [Abstract][Full Text] [Related]
16. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657
[TBL] [Abstract][Full Text] [Related]
17. Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders.
Morscio J; Tousseyn T
World J Transplant; 2016 Sep; 6(3):505-16. PubMed ID: 27683629
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant lymphoproliferative disorder in the pelvis successfully treated with consolidative radiotherapy.
Habibeh O; Elsayad K; Kriz J; Haverkamp U; Eich HT
Strahlenther Onkol; 2017 Jan; 193(1):80-85. PubMed ID: 27334275
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
